Cargando…
Safety and efficacy of weekly versus three-weekly paclitaxel plus platinum neoadjuvant chemotherapy in patients with locally advanced squamous cell head and neck carcinoma: A pilot study
BACKGROUND: Squamous cell carcinoma of head and neck (SCCHN) is one of the most common cancers seen in India and also the world. Majority of patients present in locally advanced (LA) disease where neoadjuvant combination chemotherapy with a taxane plus platinum with/without 5-Fluorouracil is the sta...
Autores principales: | Mathur, Akash, Rastogi, Naincy, Gurjar, Dinesh, Sai, Ramkrishna, Lakesar, Arvind, Malhotra, Hemant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190399/ https://www.ncbi.nlm.nih.gov/pubmed/30430095 http://dx.doi.org/10.4103/sajc.sajc_18_17 |
Ejemplares similares
-
Carcinomatous meningitis as first sign of relapse in a patient with gastric Adenocarcinoma: A rare presentation
por: Mathur, Akash, et al.
Publicado: (2017) -
The impact of 2 weeks wait referral on survival of head and neck cancer patients
por: Rovira, Aleix, et al.
Publicado: (2023) -
A prospective randomized study comparing concurrent chemoradiation with weekly and 3 weekly cisplatin in locally advanced oropharyngeal carcinoma
por: Nanda, R., et al.
Publicado: (2019) -
Prophylactic exercises among head and neck cancer patients during and after swallowing sparing intensity modulated radiation: adherence and exercise performance levels of a 12-week guided home-based program
por: Cnossen, Ingrid C., et al.
Publicado: (2016) -
A tertiary care experience with paclitaxel and cetuximab as palliative chemotherapy in platinum sensitive and nonsensitive in head and neck cancers
por: Noronha, Vanita, et al.
Publicado: (2017)